One of the more spurious and naive arguments proffered by the industry's antagonists and even some people in government is that the pricing of new treatments should reflect whether public funding contributed in any way to its development. …
Latest Video
Georgia Forrest
New Stories
-
A new prostate cancer technology moves closer to global trials after strong early results
March 12, 2026 - - Australian Biotech -
Cell therapy company Mesoblast names executive to guide clinical development and medical affairs
March 12, 2026 - - Australian Biotech -
Patrys moves toward first human trial for injectable delirium therapy
March 12, 2026 - - Australian Biotech -
Imugene launches $20 million capital raise to fund expansion of Azer Cel trials
March 12, 2026 - - Australian Biotech -
Australia at a crossroads as the nuclear medicine revolution gathers pace
March 12, 2026 - - Latest News -
New Zealand confirms earlier access to breakthrough cystic fibrosis medicines
March 12, 2026 - - Latest News -
Fundraising racing towards total target as teams and participants prepare to climb
March 11, 2026 - - Latest News